101°F
Sponsored by

Glowing Tumors

<br> <P>How lighting up cancer is helping doctors destroy the disease!<br></P>

BRAIN TUMORS WILL ATTACK 40-THOUSAND AMERICANS THIS YEAR.
REMOVING THE MALIGNANT AND MOST AGGRESSIVE FORMS CAN BE A TOUGH TASK FOR SURGEONS BECAUSE IT'S HARD TO SEE WHERE THE TUMOR BEGINS AND ENDS.... BUT AS TONIGHT'S HEALTHCAST SHOWS US GLOWING TECHNOLOGY IS SHEDDING LIGHT ON THE PROBLEM.
IN THOSE OLD SCI-FI FLICKS, DERANGED DOCTORS PERFORMED DANGEROUS EXPERIMENTS IN BLACK AND WHITE.
NOW THINGS ARE IN COLOR.
AND DEDICATED DOCTORS ARE LIGHTING UP CANCER TO KILL IT!
"A patient drinks an agent that gets metabolized by the brain cancer cells into a fluorescent compound that stays within the cells."
THE DRUG GLIOLAN HAS BEEN USED SAFELY IN THOUSANDS OF PATIENTS IN EUROPE. NOW, AT EMORY UNIVERSITY, IT'S IN ITS FIRST U-S CLINICAL TRIAL FOR PATIENTS WITH GLIOBLASTOMAS DANGEROUS BRAIN TUMORS THAT CAN BE DIFFICULT TO FULLY REMOVE. 
"It's very hard to visualize what's tumor and what's not."
WATCH WHAT HAPPENS WHEN BLUE LIGHT SHINES INTO THE BRAIN.
THE DRUG, TAKEN HOURS BEFORE SURGERY, MAKES THE TUMOR CELLS LIGHT UP, HELPING SURGEONS IDENTIFY AND REMOVE MORE OF THE CANCER. THE GLOWING TUMOR TECHNOLOGY HELPED SAFELY REMOVE AN AGGRESSIVE CANCER FROM BORIS ZEIDE'S BRAIN. 
OTHER DOCTORS SAID IT WOULD BE IMPOSSIBLE.
 "He's not just alive, he's talking."
USING SIMILAR TECHNOLOGY, THIS IS ANOTHER FLUORESCENT FIRST. IT'S FLUORESCENCE-GUIDED SURGERY BEING PERFORMED ON AN OVARIAN CANCER PATIENT.
DOCTORS SAY IT HELPED SURGEONS SPOT A TUMOR 30-TIMES SMALLER THAN THEY WOULD HAVE BEEN ABLE TO DETECT WITH STANDARD TECHNIQUES. MAKING TUMORS GLOW TO TURN THE LIGHTS OUT ON CANCER.
PHASE TWO CLINICAL TRIALS FOR FLUORESCENCE-GUIDED SURGERY STARTED IN JANUARY IN CONJUNCTION WITH THE MAYO CLINIC.  
GLIOLAN IS NOT F-D-A APPROVED AT THIS POINT, BUT MORE TRIALS ARE EXPECTED.
WHILE THE TWO METHODS CAN HELP WITH TUMOR REMOVAL, PATIENTS STILL NEED TO GO THROUGH CHEMOTHERAPY OR IMMUNOTHERAPY TO LOWER THE RISK OF THE CANCER COMING BACK.
Page: [[$index + 1]]
comments powered by Disqus

Poll

[[viewModel.Question]]

[[result.OptionText]] [[calculateVotePercent(result)]]%
[[settings.DelayedResultsMessage]]
Poll sponsored by